ZDHHC5 Mediates Immune Dysregulation Driving Generalized Anxiety Disorder Risk
Brain and Behavior · 2025-09 · 15 (9)
DOI: 10.1002/brb3.70818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 02.09.2025. Verfasst von Fuqiang Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture and Tuina, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Acyltransferases, Anxiety Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate genes associated with palmitoylation modification implicated in generalized anxiety disorder (GAD), and to elucidate the mechanistic roles of these genes via immune cell‐mediated pathways.
Methods
Utilizing large‐scale genetic datasets, genes categorized as palmitoylation‐expression quantitative trait loci (eQTL) were identified by intersecting palmitoylation‐related genes (as compiled from the most recent reviews) with genome‐wide eQTL datasets. A two‐sample Mendelian randomization (MR) methodology was applied to investigate the causal relationship between palmitoylation‐eQTL genes and GAD, with further verification conducted through summary‐data‐based Mendelian randomization (SMR) to establish the final target genes. Subsequently, the underlying mechanisms of these genes were examined through immune cell‐mediated processes.
Results
Twenty‐two palmitoylation‐eQTL gene loci were identified, among which five demonstrated a notable link to GAD: PPT2 (odds ratio [OR] = 0.844, p = 0.007), ZDHHC5 (OR = 1.101, p = 0.017), ZDHHC13 (OR = 1.175, p < 0.001), ZDHHC20 (OR = 0.874, p = 0.003), and ZDHHC24 (OR = 0.806, p < 0.001). ZDHHC5 and ZDHHC13 were validated as final target genes through SMR analysis. Mediation MR analysis revealed that SSC‐A on CD4+ T cells (mediation proportion: 36.4%) served as a mediating factor for ZDHHC5.
Conclusion
The findings indicate that ZDHHC5 contributes to the pathogenesis of GAD by modulating SSC‐A on CD4+ T cells, thereby offering novel targets for the investigation of GAD pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Acupuncture and Tuina, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Independent Researcher, Xiamen, Fujian, China.
- Department of Acupuncture, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
ORCID-Profile: Fuqiang Sun
Zitieren
APA
Sun, F., Lu, G., Li, N., Dai, K., Ren, Z., Ma, R., Feng, Y., Zong, S., & Cheng, B. (2025). ZDHHC5 Mediates Immune Dysregulation Driving Generalized Anxiety Disorder Risk. Brain and Behavior, 15(9). https://doi.org/10.1002/brb3.70818
Vancouver
Sun F, Lu G, Li N, Dai K, Ren Z, Ma R, et al. ZDHHC5 Mediates Immune Dysregulation Driving Generalized Anxiety Disorder Risk. Brain and Behavior. 2025;15(9). doi:10.1002/brb3.70818
BibTeX
@article{Sun2025,
author = {Sun, Fuqiang and Lu, Gengchen and Li, Nannan and Dai, Kun and Ren, Zhe and Ma, Ruimin and Feng, Yifei and Zong, Shuo and Cheng, Bin},
title = {ZDHHC5 Mediates Immune Dysregulation Driving Generalized Anxiety Disorder Risk},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {9},
doi = {10.1002/brb3.70818}
}
EUVIMED